Mutation accumulation has been proposed as a cause of senescence. In this process, 33 both constitutional and recurrent mutations accumulate gradually and differentially 34 among differentiating cells, tissues and organs, in relation to stage and age, analogous 35 to Muller's ratchet in asexually reproducing organisms. Latent and cascading 36 deleterious effects of mutations might initiate steady "accumulation of deficits" in cells, 37 leading to cellular senescence, and functional decline of tissues and organs, and 38 ultimately manifest as frailties and disease. We investigated a few of these aspects in 39 cell populations through modeling and simulation using the Moran birth-death process, 40 under varied scenarios of mutation accumulation. Our results agree with the principle of 41
. Fully differentiated and developed organs and organisms not only exhibit 125 individual variation for specific metric traits, but each of these traits also generally follow a 126 Gaussian distribution at population levels, a feature typical to quantitative traits. For instance, 127 measures of kidney, heart, liver, brain, and lungs vary among individuals (19, 20) . Thus, the 128 individual may be viewed as spatially organized and interacting system of polygenic 129 traits/organs. Clearly, each of these traits, and their components are subjected to age related 130 changes, just as organisms do. Hence, senescence as an intrinsic aspect of developmental 131 process would influence the G-E-P spaces of all organs, organs systems and ultimately, the 
Features of frailty:
In the life course of individuals (i.e., from fertilization to death) and 135 populations, senescence is primarily restricted to post reproductive stages, during which, 136 senescent cells accumulate in multiple tissues and organs leading to vulnerability and 137 pathogenesis of many diseases of somatic origin (21) . Consequently, post-reproductive 138 individuals start showing both physiological and functional decline, collectively termed frailty. 139 From a gerontological perspective, frailty is a stochastic and dynamic process of deficit 140 accumulation which occur ubiquitously at subcellular levels, ultimately affecting tissues, organs, 141 and integrated organ systems, especially under stress. Although some individuals have greater 142 propensity to accumulate deficits, on average, deficit accumulation varies across the life course 143 and likely is mutable. (22) . Since, cells are the primary sites of deficit accumulation, cellular 144 frailty is a major cause of declining physiological and physical functions of organs ("organ 145 deterioration"(23), resulting in single or co-occurrence of several late-onset diseases (multiple 146 morbidity). Together, these processes contribute to reduced survival ability of such phenotypes 147 (24-26). Thus, senescence, frailty and morbidities may share common origins (27) .
148
Mutations as catalysts of senescence: Among the many theories posited to explain the aging 149 process or senescence, accumulation and amplification of inherited (constitutional) and 150 acquired mutations in somatic and reproductive tissues are widely recognized as a cause of 151 aging [mutation accumulation theory (MA) (28, 29)- (Medawar 1952; Szilard 1959) . In a similar vein, Muller (30) suggested that adverse effects of numerous mutations in the genome, may 153 cumulatively create a "load" (mutational load -ML) which could become a "burden" on the 154 health of individuals in populations. The load is generated by sequential cell division initiated 155 following post-zygotic fissions, which in turn create opportunities for DNA replication errors 156 during strand segregation at every cell division event, some of which are repaired by DNA repair 157 mechanisms. Nonetheless, the "burden" of somatic mutations also increases linearly with age. 158 Although the burden of mutational load "could be measured only abstractly in terms of fitness, 159 but … felt in terms of death, sterility, illness, pain and frustration" (31). Indeed, a few of these 160 factors mediate both frailty and morbidity. Subtle differences aside, both MA and ML theories 161 address the same issue; i.e., adverse effects of mutations on somatic and reproductive tissues, 162 and ultimately, overall health. 163 The MA process is a gradual and ubiquitous feature among all differentiating cell 164 lineages within tissues and organs, and organ systems within the organism -a process 165 comparable to asexually or clonally reproducing organisms. In fact, "the dividing zygote is a senescence, frailty and multimorbidity has not received much attention. We have two objectives 227 in this study: a) to apply Muller's ratchet principle to aging process in somatic tissues, and b) to 228 discuss the utility of evolutionary genetic mechanisms toward understanding the origins of frailty, 229 morbidity and senescence. We make the following assumptions: 1) cell is the primary unit of 230 differentiation, development, and regeneration and also represents correct abstraction of the 231 individual(55, 56); 2) All organs and mosaics within an individual are derived from the same zygote 232 (cell), yet they are differentiated, connected, function autonomously, and might be exposed to 233 the same or different environmental conditions; and 3) cellular senescence (57) is both a norm 234 and a precursor to other known degenerative processes in tissues, organs and ultimately the 235 organism; but could also influence regeneration and tissue remodeling (25, 47). Among respectively, over all cells in the population at time t. 251 As illustrated in Figure 2 , any tissue is a population of cells, in which each of the 252 constituent cells are genetically variable (hence different genotypes) and some are more 253 variable than others. The population proliferate from a single cell, and the cell population size 254 at time t is denoted by N(t), and t represents age and t starts at t =-1 (roughly corresponding to 255 the time of fertilization and zygote formation). N(t) is assumed to increase up to K, which 256 represents the population size of an adult. Then, as aging proceeds, N(t) could start declining. 257 This assumes well-known phases of density dependent population growth (lag, stationary, 258 decline), as well as exhibit the salient features typical to such populations -connectivity, 259 cooperation, competition and coevolution (59, 60). Thus, the process may be divided into three 260 phases ( Figure 2B ). The first phase (Phase I -lag) is from the initial state to T1, after which N(t) = 261 K (Phase II -stationary). T2 is the time when N(t) starts declining, and this phase is referred to as 262 Phase III. 263 In this work, we modified the Moran model such that we can incorporate the change of 264 population size as illustrated in Figure 2B . In brief, we introduce a parameter U(t), an upper 265 limit of the population size (e.g., all healthy tissues and organs have a species specific size limit). 266 The population can increase up to U(t) if B(t) > D(t), but the population will decrease in size if
When the tissue is young and healthy enough (B(t) > D(t)), the population size is kept 268 at U, but as all cells in a tissue accumulate deleterious mutations and D becomes greater than 269 B, the population size starts declining. See supplementary part for theoretical details.
270

Results
271
Our model incorporating demographic changes provides a simulation framework for exploring 272 the aging process in growing cell populations. In addition, some analytical expressions on the 273 nature of mutation accumulation during aging process may be obtained with simple and 274 biologically justifiable assumptions. We first describe the theoretical results to gain insights into 275 the mutation accumulation process through aging process or cellular senescence (4), followed 276 by more detailed analyses by simulations.
277
Theory: Let us first focus on Phase I, in which B(t)/D(t)>>1 and D(t) is so small that most events 278 are cell divisions due to an increase of U(t) and N(t). We then derive approximate expressions 279 for the number of somatic (S) mutations, Save(t) and Stotal (t), the average and total numbers of 280 mutations that cells have accumulated by time t (i.e., Stotal(t)= Save(t)N(t)). Consider a situation 281 where there are N cells waiting for an increase of N to N+1 by division. If a cell having s 282 mutations (constituent) undergoes a cell division, its two daughter cells will have s mutations 283 plus new mutations that occur at rate  in one cell and at a rate (1-) in the other. 284 Therefore, when N increases by one through a single cell division event, the expected increase 285 of Stotal(t) is Stotal(t)/N(t)+. Thus, S increases as N increases, and if we ignore death events, (2) 290 Stotal (t) is thus given by a function of it if N (t) (or U (t)) is specified (e.g., see equation (S1 in 291 supplementary information). 292 If cell death (apoptosis and necroptosis) is taken into account, we consider two paths 293 from N to N+1 by assuming the time interval (t) from N to N+1 is so small (i.e. time taken for one cell division) that at most one cell death occurs in t. The first path is that a single cell 295 division increases N to N+1, as described above. The second path involves a cell death, and the 296 dead cell is eliminated by intercellular competition, which changes N to N-1. Then, two cell 297 divisions follow and the population size becomes N+1, according to the assumption of a very 298 small t (so that multiple death events are not considered). Let p be the probability that the 299 system goes through the second path. Because the expected increase of mutations is 300 Stotal(t)/N+2 in the second path, Equation (5) may be written as
where, p=D(t)t. t depends on the growth function, U(t). 303 The process of mutation accumulation in phase II is quite simple because a death event 304 is always coupled with a cell division. That is, the accumulation of mutations simply depends of 305 the death rate, D(t):
This process is analogous to mutation accumulation in constant-size asexual populations also 308 called, Muller's ratchet, which reduces fitness (61). from Phase II to Phase III. Because it is not very straightforward to evaluate Save(t) with the 348 above equations, we performed a number of runs of simulations. As well as Figure 2 , r=0.5 and K=100 were assumed. For convenience, it is assumed that a deleterious mutation affects f, b 350 and d equally, that is, f = b = d = . b0=0.1 was assumed and we changed d0 to vary 351 the speed of aging. 352 The consensus we found in a number of simulation runs is that the tissue degrades 353 gradually over time, as expected for frailty, and that it will eventually reach physiologically the cell populations enter a declining phase (i.e., B<D). This trend also corroborates with the 408 Hayflick limit, which suggests that normal healthy cells in culture will divide between 40 and 60 409 times before reaching a plateau afterward their density declines due to senescence. Third, if 410 cells are dividing abnormally fast (Fig. S1C) , they might survive for about 15 years (e.g., 411 Hutchinson-Gilford syndrome). However, it is likely that the health status of various tissues and divergence of somatic tissues (82) and subsequently influence the frailty among physiological, 464 anatomical and morphological traits. In fact, while networks confer stability to biological systems (83), instability could lead to multiple organ dysfunctional syndrome (MODS (67)] . 466 Obviously fitness could change among the divergent population (crypts) of cells, within tissues 467 in relation to number of mutations (31, 83 ). An excellent example of this process was recently 468 provided by (84)(85), epilepsy (86), cardiovascular and skeletal disorders (21) as well as several 469 brain disorders including cerebral palsies (87) and cortical malformation (88). A 470 comprehensive list of diseases associated with many organs and their component tissues (25) 471 clearly suggests phenotypic manifestation of interaction among developmental disorders and 472 frailty leading to multimorbidity. A more recent study involving more than 3000 families (89) 473 and coworkers have reported that diseases of de novo origin may be more common than 474 previously thought, and could affect nearly four million children worldwide, annually. Similarly, 475 somatic origins of late onset complex disorders such as stroke, demyelination, optic nerve 476 disorders and brain cancers represent only the "tip of the iceberg" (90) of numerous disorders, 477 yet to be described. 478 There are limitations to our study, however. Since our goal was to extend Muller's 479 ratchet principle to link cellular senescence and frailty, we modeled these processes, based on 480 average mutation accumulation in populations of brain cells as example. The model could be 481 extended, however, to other tissues assigning tissue specific mutation rates (91), and 482 recruitment cycle of cells, which are often context dependent, as discussed. We have relied on 483 mutation accumulation process in asexual lineages, in which Muller's ratchet has been 484 suggested to operate. In our model, the growth parameter for cells, "U" is greater at the initial 485 stages (phase 1 -childhood), later it becomes fairly stable, but decreases at later ages. These Another limitation is that we considered a population of stem cells, which accumulate 493 mutations when a stem cell undergoes cell division to produce another daughter stem cell.
However, there are at least two factors that could induce mutations into stem cells. One is 495 mutations that arise during the division and differentiation of stem cells, and the other is 496 mutations that are induced by the micro-environment of the tissue (94). These two factors can 497 be incorporated in our derivation (equations 1-5) by replacing by µ and µ', where µ' is defined 498 as the total mutation rate including these two factors. These two factors well explain the 499 observed exponential increase of SNVs after 80 yr. in brain (75). They also explain the recently 500 reported almost star-shaped tree of hematopoietic stem cells (38). The tree indicates that the 501 hematopoietic stem cell population grows rapidly and reaches a plateau, and since then they 502 accumulate mutations by producing additional progenitor cells. 503 In conclusion, the Muller's ratchet principle provides a rational foundation to study 504 the origin, maintenance or augmentation of vulnerability, frailty, morbidity and mortality 505 associated with aging as well as many inherited and latent disorders. The principle focuses on 506 generally predictable effects of mutation accumulation on the aging phenotypes and 507 compliments two well-known mechanisms of aging -the Hayflick limit and mutation rate (91, 508 95). This trend is also reflected at the genomic level in hematopoietic cells (38) . Note that 509 mutation rates, telomere shortening and the Hayflick process represent, respectively, cell is randomly chosen according to its relative contribution to the population birth rate, B(t). 867 Second, in addition to cell death, our model creates empty slots when U(t) increases. When an 868 empty slot arises at time t, it is assumed that the slot is immediately filled (as the Moran model 869 does) when the population has sufficient reproductive ability, that is, B(t)/D(t)>1, otherwise the 870 probability of successful reproduction is given by B(t)/D(t). For simulating the aging process, the 871 system starts with B(t) much higher than D(t), such that empty slots are immediately filled in 872 Phases I and II. In our setting, B(t) and D(t) monotonically increases and decreases as the 873 process proceeds, so that T2 is considered as the time when B(t) first becomes lower than D(t), 874 (i.e., B(T2) ~ D(T2)). Thus, we cannot explicitly specify when the phase shifts from II to III. Rather, 875 Phases II and III are defined such that phase III starts when N(t) starts declining. Therefore, T2 876 could differ among independent realizations with the identical parameter set. In Phase III, as a 877 new cell can arise only when a cell dies in Phase III (as well as Phase II), once a slot is not 878 successfully filled, it remains empty for the rest of the process, thereby resulting in an 879 irreversible decrease of the population size (e.g., osteoporosis, sarcopenia, neurodegeneration 880 in Alzheimer's diseases). The process is terminated when the cell population (tissue) reaches functional attenuation due to dysregulation of physiological processes (melts down sensu (45) 882 Lynch et. al 1993), that is, F(t) first hits a threshold value, LF. 
